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Abstract
Osseointegrated implants have been an optimal treatment option for dental 
rehabilitation of fully or partially edentulous patients. Although peri-implantitis 
remains as the most common local risk factor for dental implant failure, the 
development of oral cancer involving the soft tissue around the titanium may lead 
to early implants loss and impact the quality of life of the patient negatively. Oral 
squamous cell carcinoma (OSCC) is the most common malignancy among head and 
neck tumors. It has higher prevalence in men over 50 years old, and in tobacco and/
or alcohol users. Unfortunately, oral cancer is often detected in advanced stages, 
when the treatment options are limited. Thus, OSCC typically has poor prognosis. 
Despite the recent advances in oral carcinogenesis understanding, the relationship 
between dental implants and the development of malignant lesions around them is 
not completely understood. It has been suggested that the titanium corrosion occur-
ring at the top of dental implants causes the release of metal ions. These ions might 
lead to oral epithelial genetic damage and higher susceptibility of normal mucosa 
to malignant transformation. The aim of this chapter was to review the clinical 
characteristics, diagnosis, and the possible carcinogenic mechanisms involved in 
oral cancer around dental implants.
Keywords: oral cancer, carcinogenesis, dental implants, titanium corrosion,  
delayed diagnosis
1. Introduction
Oral cancer remains as a significant cause of mortality worldwide as most of 
these the tumors are detected and treated in late stages. The etiology of oral cancer 
is multifactorial. Tobacco and alcohol are still considered the main risk factors as 
about 80% of the patients who develop oral tumors are tobacco and/or alcohol 
users [1]. Additional etiologic factors have also been suggested such as infection by 
human papillomavirus (HPV) and other oncogenic viruses, immunosuppression 
states, genetic alterations, and deficient nutrition.
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Dental implants are one of the top choices for the oral rehabilitation of partially 
or totally edentulous patients. The stability and comfort provided by the implants-
anchored crowns are among their clinical advantages. Moreover, the success rate 
of dental implants surpasses 94.6% [2]. However, the soft tissue and supporting 
structures around the dental implants remain exposed to the oral cavity and may 
undergo pathological changes. The most frequent lesions are those of inflammatory 
nature triggered by the accumulation of bacterial biofilm. When the inflamma-
tory lesion is confined to the soft tissue, it is named as peri-implant mucositis. 
On the other hand, when there is loss of supporting bone, the lesion is known as 
peri-implantitis. Due to the high incidence of peri-implant inflammatory diseases, 
some dental professionals treat the lesion but do not send the specimens to the 
microscopical analysis. About 3.6% of the lesions are malignant tumors (mainly 
squamous cell carcinomas, the most common malignancy of the oral cavity) [3]. In 
2001, the first cases of malignant lesions developing around dental implants were 
published [4–22]. Since then, the potential relationship of titanium implants with 
malignant tumor development has been discussed [1, 5, 13].
The aim of this chapter was to offer the readership the most recent information 
regarding the clinical features of oral cancer around dental implants, its differential 
diagnosis, and potential oncogenic mechanisms.
2. Clinical features of oral cancer around dental implants
A review of literature available until September 2021 was conducted in the 
PubMed/Medline database using the term “Oral squamous cell carcinoma around 
dental implants.” Only cases with definitive microscopic diagnosis of OSCC arising 
in the soft tissue around one or more dental implants were included. The literature 
review revealed 43 cases of patients with OSCC around dental implants in the 19 
published manuscripts [4–22]. All clinical and epidemiological information about 
the sample is summarized in the Table 1.
The age of patients with oral cancer around dental implants ranged from 61 to 
75 years old. There was a predominance of females (24 cases - 57.14%) when  
compared to males (18 cases - 42.86%). The typical clinical appearance of oral cancer 
around dental implants was an exophytic mass (20 tumors—47.62%) with few cases 
presenting as ulcer (4 tumors—9.52%). The bone osteolysis was frequently observed 
in the area of tumor causing the implant loss in some patients. The tumors affected 
mainly mandible (38 cases—90.47%) of the patients with multiples osseointegrated 
implants. Of note, oral cancer around dental implants is frequently clinically mistaken 
as peri-implantitis (Table 1).
Although peri-implantitis is the most common local risk factor for dental 
implant failure, the development of oral cancer involving the soft tissue around the 
titanium also impact the quality of life of the patient negatively. The oral cancer 
can manifest as hypertrophy, erythema, and/or ulcerative lesion of the soft tis-
sue, and these features are similar to inflammatory peri-implant diseases such as 
peri-implantitis and/or peri-implant mucositis, as described by others [7, 10, 11]. 
Furthermore, these inflammatory peri-implant diseases frequently present the 
same epidemiological pattern and risk factors for oral cancer, that is, patients older 
than 60 years old and chronic tobacco and/or alcohol consumers [1]. Although 
there are protocols for peri-implantitis treatment, frequently, the peri-implant 
tissue removed during this surgical treatment is not submitted for histopathological 
analysis [23, 24] Then, the number of reported cases of peri-implant malignancy 
seems to be low in mouth but it may be being underreported by health profession-
als [24]. Recently, in a study of 111 biopsies of peri-implant lesions, 3.6% of those 
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Block et al. 2001 [4] M/72 Mandible Mimicked PI Yes Yes PI
Shaw et al. 2004 [5] M/67 Mandible Exophytic mass NA Yes PI
F/69 Mandible Mimicked PI NA Yes NA
Czerninski et al. [15] F/52 Mandible Mimicked PI Yes No PI
M/80 Mandible Mimicked PI No Yes PI
Abu El Naaj [16] F/70 Mandible Exophytic white No Yes NA
Schache el al. [17] F/77 Mandible Exophytic mass No No NA
Gallego et al. [18] F/81 Mandible PI mass No Yes OL
Kwok et al. [19] M/71 Mandible “Inflammatory 
process”
Yes No PI
F/67 Mandible Exophytic mass Yes Yes NA
M/62 Mandible Non-healing ulcer Yes No Na
De Ceulaer et al. [20] F/77 Mandible Mimicked PI Yes Yes PI
M/71 Mandible Swelling Yes Yes PI
F/62 Mandible Mimicked PI Yes Yes PI
Meijer et al. [21] F/69 Mandible Exophytic mass No Yes PI





Pfammatter et al. [6] F/55 Mandible mimicked PI, 
numbness
Na Yes Metastasis
Moergel et al. [7] F/63 Mandible Exophytic mass No Yes NA
F/70 Mandible Exophytic mass Yes Yes NA
M/72 Mandible Exophytic mass No Yes NA
M/57 Mandible mimicked PI Yes Yes PI
M/72 Mandible Exophytic mass NA No NA
F/54 Mandible Exophytic mass No NA NA
M/47 Mandible Ulcer Yes No NA
M/88 Mandible Ulcer No No NA
F/42 Mandible Ulcer NA Yes NA
F/59 Mandible Ulcer NA Yes NA
M/73 Maxilla Exophytic mass Yes Yes NA
M/77 Mandible Exophytic mass Yes No NA
F/68 Mandible Exophytic mass Yes Yes NA
F/69 Mandible Exophytic mass No Yes NA
Marini et al. [8] F/51 Mandible Exophytic mass No No PI
Bhandari et al. [9] F/71 Maxilla Erythematous No No PI
Chainani-Wu et al. [10] F/60 Maxilla Fistula No No PI
Vadim Raiser et al. [11] F/55 Maxilla White Exophytic 
mass
NA NA OL
F/70 Mandible Erythematous mass NA NA NA
Oral Health Care
4
had histopathological diagnosis of oral squamous cell carcinomas [3]. Another 
investigation demonstrated that 2.9% of 68 dental implant-related lesions were oral 
squamous cells carcinomas [25].
Figure 1 illustrates a case report of an edentulous 64-year-old woman. She 
had an exophytic mass associated with ulcerated area and covered by a yellow-
ish membrane in the anterior region of the mandible. The lesion was surrounded 
multiple osseointegrated implants (Figure 1A). She did not report adverse habits, 
for example, tobacco or alcohol consumption. Periapical radiographic exhibited 
an ill-defined bone destruction underneath the area of the lesion (Figure 1B). The 
Figure 1. 
Clinical and microscopic findings of oral squamous cell carcinoma around dental implants. a) Exophytic ulcer 
covered by necrotic tissue at the anterior-inferior alveolar ridge.b) Periapical radiograph showing an ill-defined 
bone loss in the peri-implant region. c) Neoplastic squamous epithelium-infiltrating subjacent submucosa with 
corneal pearls and discrete pleomorphism. d and e) epithelial cells with atypical mitotic figures infiltrating the tissue.







Noguchi et al. [12] F/65 Mandible gingival swelling Yes NA Neoplasia
Malthiéry et al. [13] M/77 Mandible Mimicked PI NA No PI
Granados et al. [14] M/83 Mandible Ulcerous lesion NA Yes NA
M/60 Mandible Verrucous lesion NA NA NA
F/54 Mandible “Gum lesion” NA NA NA
M/64 Mandible Excrescent lesion NA NA NA
M = Male; F = Female; Pre.Rep.CA = Previously reported cancer; PI = Peri-implantitis; OL = Oral lichen planus; 
NA = Not available. * Patients who smokers and/or drinkers were considered.
Table 1. 
Demographic and clinical features of patients diagnosed with oral squamous cell carcinoma around dental 
implants.
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histopathological analysis exhibited keratinizing well-differentiated epithelial neo-
plastic cells, some undergoing atypical mitosis, and invading the subjacent fibrous 
connective tissue (Figure 1C). The diagnosis of oral cancer was confirmed.
The early diagnosis of malignant tumors around dental implants is challenging 
because incipient lesions may resemble inflammatory peri-implant lesions [1, 2, 
4–7, 10, 12, 15–18, 21]. In the Table 1, 14 out of 43 cases of oral cancer surround-
ing dental implants (33.33%) had the primary diagnosis of peri-implant lesions. 
Therefore, this clinical misinterpretation might delay the diagnosis of oral cancer 
facilitating its dissemination and resulting in a worst prognosis of the disease. 
These facts underscore how critical is the histological exam of every lesion around 
dental implants surgically removed. Furthermore, the peri-implant lesion that does 
not present the classical features of an inflammatory condition and that does not 
respond to conventional treatment, particularly if the patient has risk factor for oral 
cancer, should be submitted to the biopsy and histopathological analysis [23–25].
3. Risk factors for oral cancer around dental implants
The etiology of oral cancer is multifactorial. OSCC is the most prevalent oral 
malignant tumor and it is associated with lifestyle risk factors such as alcohol con-
sumption and smoking [26]. Curiously, tobacco smoking is also the predictor of den-
tal implants failure and more smokers have post-operative infections and peri-implant 
crestal bone loss than nonsmokers [27, 28]. Although the information about lifestyle-
related factors that predispose to oral cancer was incomplete in most of cases included 
in the Table 1, 34.88% of patients diagnosed with squamous cell carcinoma around 
dental implants were smokers and/or drinkers. These overlapping risk factors may 
drive the clinician to attribute the onset of an atypical lesion involving dental implants 
to a deficient or anomalous immune response of a patient who consumes tobacco and/
or alcohol. However, it is essential that the clinicians are aware that the classic signs of 
inflammation persist in such patients and that these features are useful to distinguish 
a benign from a malignant lesion. Additionally, the histopathological analysis remains 
as the gold standard for the diagnosis of lesions located in the oral cavity [23].
A well-defined concept is that patients with previous history of cancer have 
higher risk of developing other tumors. Twenty-three (54.76%) of all cases of 
squamous cell carcinoma around dental implants arose in patients with history of 
cancer. Interestingly, we observed that 19 (82.60%) patients had OSCC previously. 
Furthermore, other patients had lung [6, 15], intestine [15], thyroid [17], and breast 
[17, 22] cancer previously. As the development of OSCC has been also associated 
with genomic instability and genetic predisposition [1], one can hypothesize that a 
patient who had a malignant lesion are more susceptible to local aggressions such as 
the contact of the soft tissue with dental implant materials.
4.  Carcinogenic mechanisms associated with osseointegrated dental 
implants
Titanium is one of the most common components in implants alloys used in 
dental and medical fields [1, 29]. High biocompatibility, appropriate mechanical 
properties, inertness, and corrosion resistance are among the main advantages 
of titanium [25, 29, 30]. When the titanium implant is installed in extra oral 
sites, where it is protected from the contact with the environment, it has inert 
behavior. On the other hand, dental implants are continuously exposed to the oral 
cavity hostile conditions [31]. The area between the implants and the abutment 
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or the prosthetic crown is particularly susceptible to the bacterial biofilm accu-
mulation, saliva, pH and temperature changes, and functional micromotion 
(Figure 2) [31].
When the dental implant surface is exposed to any source of oxygen or nitro-
gen, a chemical reaction takes place and a thin layer of titanium dioxide (TiO2) is 
formed and deposited in the outer surface of the implants. This layer is extremely 
resistant to corrosion. However the chemical agents of the oral cavity can reduce 
the protection of the dioxide deposit and induce the corrosion development [31]. 
Saliva and other chemicals introduced into the oral cavity through feeding or in 
contact with bacterial biofilms influence the gradual biodegradation of metallic 
structures including the titanium used in dental implants [29]. Furthermore, 
acidic solution combined with mechanical friction strength potentiates the 
damages to the implants surfaces. Interestingly, some studies with cytology have 
demonstrated the presence of titanium particles in the peri-implant tissues [23, 
25] regardless of the presence of peri-implantitis or peri-implant mucositis. It has 
been suggested that this material accumulation may be the result of the corrosive 
process of the dental implants [29, 30, 32], implant-abutment friction at the 
installation of the implants, and/or implantoplasty [29, 31, 33, 34]. The degree of 
titanium corrosion can be influenced by quality and quantity of saliva, diet, alloy 
polishing, genetics, oral hygiene, amount and distribution of the occlusal forces, 
and microbiota [29, 30, 32].
The above data show that titanium is not entirely bioinert as suggested years 
ago. Then, even with their good biological properties, titanium alloys are suscep-
tible to corrosion attack with release of metal ions to the surrounding hard and soft 
oral tissues, lymph nodes, peripheral, and even distant organs [30]. Consequently, 
titanium ions have been implicated in the development of oral cancer around 
dental implants [1, 34].
As stated previously, the relationship between titanium dental implants 
and oral cancer has been suggested based on the increasing number of tumors 
arising in the peri-implant tissue. However, as far as we know, there is not any 
study dedicated to unveil the potential carcinogenic mechanisms triggered by 
titanium ions.
Figure 2. 
Illustration of potential risk factors and mechanisms on the development of squamous cell carcinoma around 
dental implants.
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Titanium particles have been shown to induce the expression of breast cancer 
gene 1 (BRCA1) and checkpoint kinase 2 (CHK2) in epithelial cells in vitro [35]. 
These proteins are markers of DNA damage response. Additionally, titanium also 
triggered the generation of reactive oxygen species (ROS) [36, 37]. The chronic 
exposure of the epithelial cells to aggressive factors may increase the probability of 
mutations that might not be detected by the immune system. Indeed, the chronic 
inflammatory response seems to be also modulated by titanium, especially when 
there is accumulation of bacterial biofilm. Higher amounts of titanium ions in 
peri-implant soft tissue with inflammatory process are observed when compared to 
healthy tissues [25, 38]. Accordingly, titanium nanoparticles induced stronger pro-
inflammatory response in macrophages regardless of the association with lipopoly-
saccharide from Porphyromonas gingivalis [40] and by increasing the secretion of 
interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha (TNF-α) by macrophages 
in vitro [38, 40]. Taken together, all these disturbances in the peri-implant micro-
envinoment may persist for years and, gradually, predispose the epithelial cells to 
sequential mutations until the malignant state is reached.
In 2006, the International Agency for Research on Cancer (IARC) classified 
the titanium dioxide as a possible carcinogen for humans [41]. However, in view 
of the few case reports of oral cancer around dental implants the authors were 
unable to exclude the existence of other confounding carcinogens as tobacco 
and/or alcohol [1, 7, 19].
5. Conclusion
The literature review showed that most cases of OSCC around dental implants 
had initial clinical features compatible with peri-implantitis. Therefore, this clinical 
misinterpretation of an inflammatory process in peri-implant mucosa may delay 
the diagnosis of oral cancer facilitating the local progression and dissemination of 
cancer cells, resulting in worst patient’s prognosis. Thus, the peri-implant lesion not 
responding to conventional anti-inflammatory treatment, particularly if the patient 
has risk factor for oral cancer, should be submitted to the biopsy and histopatho-
logical analysis, avoiding delay in the diagnosis of the tumor.
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